76 related articles for article (PubMed ID: 24008612)
1. Efficacy of cefixime plus metronidazole therapy for Helicobacter pylori eradication: a retrospective study.
Adriani A; Astegiano M; Smedile A; Rizzetto M; Pellicano R
Minerva Med; 2013 Aug; 104(4):495-6. PubMed ID: 24008612
[No Abstract] [Full Text] [Related]
2. Efficacy of cefixime-based triple therapy for Helicobacter pylori eradication: a retrospective study.
Fagoonee S; Astegiano M; Smedile A; Pellicano R
Panminerva Med; 2013 Sep; 55(3):309-10. PubMed ID: 24088806
[No Abstract] [Full Text] [Related]
3. Efficacy of clarithromycin plus metronidazole-based triple therapy for Helicobacter pylori eradication: a retrospective study.
Berrutti M; Fagoonee S; Strona S; Astegiano M; Morgando A; Rizzetto M; Pellicano R
Minerva Med; 2010 Dec; 101(6):457-8. PubMed ID: 21196905
[No Abstract] [Full Text] [Related]
4. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
Wong WM; Huang J; Xia HH; Fung FM; Tong TS; Cheung KL; Ho VY; Lai KC; Chan CK; Chan AO; Hui CK; Lam SK; Wong BC
J Gastroenterol Hepatol; 2005 Jun; 20(6):935-40. PubMed ID: 15946144
[TBL] [Abstract][Full Text] [Related]
5. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
6. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study.
Kudo T; Fujinami H; Ando T; Nishikawa J; Ogawa K; Hosokawa A; Orihara T; Murakami J; Takahara T; Sugiyama T
Helicobacter; 2012 Aug; 17(4):277-81. PubMed ID: 22759327
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
9. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J
Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152
[TBL] [Abstract][Full Text] [Related]
10. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
[TBL] [Abstract][Full Text] [Related]
11. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.
Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F
Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.
Chiba N; Rao BV; Rademaker JW; Hunt RH
Am J Gastroenterol; 1992 Dec; 87(12):1716-27. PubMed ID: 1449132
[TBL] [Abstract][Full Text] [Related]
13. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
14. Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication.
Tursi A; Cammarota G; Papa A; Montalto M; Fedeli G; Gasbarrini G
Am J Gastroenterol; 1996 Aug; 91(8):1668-70. PubMed ID: 8759696
[No Abstract] [Full Text] [Related]
15. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.
Sezgin O; Altintaş E; Nayir E; Uçbilek E
Helicobacter; 2007 Dec; 12(6):629-32. PubMed ID: 18001405
[TBL] [Abstract][Full Text] [Related]
16. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
17. Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).
Koizumi W; Tanabe S; Nakatani K; Ishido K; Nishimura K; Azuma M; Ae T; Sasaki T; Higuchi K; Katada C; Nakayama N; Saigenji K
J Clin Pharm Ther; 2010 Jun; 35(3):303-7. PubMed ID: 20831531
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Miehlke S; Hansky K; Schneider-Brachert W; Kirsch C; Morgner A; Madisch A; Kuhlisch E; Bästlein E; Jacobs E; Bayerdörffer E; Lehn N; Stolte M
Aliment Pharmacol Ther; 2006 Jul; 24(2):395-403. PubMed ID: 16842467
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.
Kim SY; Lee SW; Hyun JJ; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Choi JH
J Clin Gastroenterol; 2013 Jan; 47(1):21-4. PubMed ID: 22647826
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options after failed Helicobacter pylori eradication therapy.
van der Hulst RW; Weel JF; van der Ende A; ten Kate FJ; Dankert J; Tytgat GN
Am J Gastroenterol; 1996 Nov; 91(11):2333-7. PubMed ID: 8931413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
